COMMUNIQUÉS West-GlobeNewswire

SPINEWAY : Great success at the 24th AMCICO Congress in Mexico

12/09/2024 - 18:00

Press release Ecully, September 12, 2024 – 6 p.m. SPINEWAY Great success at the 24th AMCICO Congress in Mexico Spineway , a specialist in innovative implants for the treatment of severe spine disorders, took part in the [...]

SPINEWAY : Fort succès au 24ème congrès AMCICO au Mexique

12/09/2024 - 18:00

Communiqué de presse Ecully, le 12 septembre 2024 – 18h SPINEWAY Fort succès au 24 ème congrès AMCICO au Mexique Spineway , spécialiste des implants innovants pour le traitement des pathologies sévères de la colonne [...]

North Western Toronto Ontario Health Team Celebrates the Grand Opening of Innovative Community Hub

12/09/2024 - 17:42

One-stop shop for community services aims to improve access, coordination, wait times and outcomes TORONTO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- The North Western Toronto (NWT) Ontario Health Team (OHT) has officially [...]

Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

12/09/2024 - 17:01

Company announcement – No. 45 / 2024 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark, September 12, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) ( [...]

Le KFSHRC annoncé comme partenaire stratégique du Sommet C3 Davos of Healthcare 2024 de New York

12/09/2024 - 16:10

RIYAD, Arabie saoudite, 12 sept. 2024 (GLOBE NEWSWIRE) -- Dans le but de renforcer sa présence à l'international, le King Faisal Specialist Hospital & Research Centre (KFSHRC) s’apprête à devenir un partenaire clé [...]

USAHS Announces Upcoming 2024 Mental Health Summit Event to Boost Mental Health Care Support and Services

12/09/2024 - 16:05

Participants will engage with experts and best practices, earn continuing education units, explore innovative approaches to behavioral and psychiatric health. ST. AUGUSTINE, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- [...]

Viva Naturals Triple-Strength Omega-3 Fish Oil Supplement Offers Convenient Softgel and Health-Boosting Formulation

12/09/2024 - 16:03

Featuring purified fish oil and encapsulated in a pescatarian-friendly softgel, Viva Naturals’ Triple-Strength Omega-3 Fish Oil Supplement offers the height of quality and fast absorption NORTH YORK, Ontario, Sept. 12, [...]

WellRithms Hosts Webinar on Risk Management Solutions to Combat High-Cost Medical Claims

12/09/2024 - 16:00

PORTLAND, Ore., Sept. 12, 2024 (GLOBE NEWSWIRE) -- WellRithms , the industry leading payment integrity firm, today announces that it will host a complimentary webinar, “ Stem the Rise of High-Cost Medical Claims: Key [...]

Thought Leadership & Innovation Foundation (TLI) Announces Partnership with OneStep to Advance Data-Driven Research in Limb Loss and Preservation

12/09/2024 - 16:00

MCLEAN, Va., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Thought Leadership & Innovation Foundation (TLI) , a not-for-profit organization that works at the nexus of science, technology and public health, is proud to announce [...]

A Pioneering Achievement Strengthening the Kingdom's Leadership in Medicine

12/09/2024 - 15:37

KFSHRC Performs the World’s First Fully Robotic Heart Transplant RIYADH, Saudi Arabia, Sept. 12, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) successfully performed the world’s [...]

FibroBiologics Announces Filing of Patent Application for Generation of Functional Hematopoietic Organoids using Fibroblast Cell-Based Technology

12/09/2024 - 15:31

HOUSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of [...]

Kriya Highlights Positive Preclinical Data for KRIYA-586, a Gene Therapy Product Candidate for Thyroid Eye Disease (TED), at ESOPRS Annual Meeting

12/09/2024 - 15:05

– Preclinical data demonstrate pharmacodynamic activity of KRIYA-586, an investigational gene therapy which encodes for an anti- IGF1R antibody – – Kriya anticipates advancing KRIYA-586 into the clinic in 2025 to [...]

University of California Transforms Life Science Research Procurement with Labviva

12/09/2024 - 15:00

University of California selects AI purchasing platform to accelerate scientific and research procurement for 10 campuses OAKLAND, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- The University of California (UC) has [...]

Streamline Health® Reports Fiscal Second Quarter 2024 Financial Results

11/09/2024 - 22:30

Net loss of ($2.8 million) during the second quarter of fiscal 2024 compared to a net loss of ($2.5 million) during the second quarter of fiscal 2023 Adjusted EBITDA improved to a loss of ($0.3 million) for the second [...]

Teva to Present at the Bank of America 2024 Global Healthcare Conference

11/09/2024 - 22:30

TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Bank of America 2024 [...]

iSpecimen Announces 1-for-20 Reverse Stock Split

11/09/2024 - 22:30

WOBURN, Mass., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]

Umoja Biopharma to Present at the 9th Annual CAR-TCR Summit

11/09/2024 - 22:30

SEATTLE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a transformative immunotherapy company creating off-the-shelf treatments that aim to extend the reach and effectiveness of CAR-T cell therapies [...]

Annual Report 2023/24 - Strengthened commercial focus after challenging year

11/09/2024 - 22:29

ANNOUNCEMENT NO. 273 11 September 2024 Annual Report 2023/24 (1 July 2023 - 30 June 2024) Strengthened commercial focus after challenging year ChemoMetec’s revenue fell by 8% in 2023/24 to DKK 407.4 million, and [...]

Guidance for the 2024/25 financial year

11/09/2024 - 22:27

ANNOUNCEMENT NO. 272 11 September 2024 Guidance for the 2024/25 financial year ChemoMetec has today approved the annual report for 2023/24, including the guidance for 2024/25, which is considered inside information. For [...]